ArticleCancer immunology, immunotherapy : CII2019

The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial.

Charlotte M Huijts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.